Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Myelodysplastic Syndrome”

180 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 180 results

Early research (Phase 1)Study completedNCT00125840
What this trial is testing

Clofarabine in Adult Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorsLeukemia, Lymphocytic, Acute, PediatricLeukemia, Lymphocytic, Acute, Adult+3 more
Genzyme, a Sanofi Company
Early research (Phase 1)Study completedNCT01139151
What this trial is testing

4'-Thio-araC (Thiarabine) in Advanced Hematologic Malignancies

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 31
Testing effectiveness (Phase 2)Study completedNCT00352001
What this trial is testing

Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic Syndromes

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Mikkael Sekeres MD 37
Early research (Phase 1)Study completedNCT00867230
What this trial is testing

FTS Study in Patients With Advanced Hematologic Malignancies

Who this might be right for
Myelodysplastic SyndromeLeukemia
M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)Looking for participantsNCT04068597
What this trial is testing

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Who this might be right for
Haematological MalignancyAcute Myeloid LeukemiaNon Hodgkin Lymphoma+3 more
CellCentric Ltd. 250
Early research (Phase 1)Temporarily pausedNCT02333162
What this trial is testing

Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant

Who this might be right for
Previously Treated Myelodysplastic SyndromeRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent Adult Acute Myeloid Leukemia+1 more
University of Chicago 30
Early research (Phase 1)Study completedNCT01463046
What this trial is testing

Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaAdvanced Myelodysplastic Syndrome
University of California, San Francisco 29
Not applicableStudy completedNCT01807091
What this trial is testing

Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

Who this might be right for
Adult Acute Myeloid LeukemiaAdult Myelodysplastic Syndrome
University of Washington 17
Early research (Phase 1)Ended earlyNCT05607199
What this trial is testing

A First in Human Study of AUR 103 Calcium to Evaluate Safety, Pharmacokinetics and Pharmacodynamics

Who this might be right for
Solid Tumor, AdultAcute Myeloid LeukemiaMyelodysplastic Syndromes+1 more
Aurigene Discovery Technologies Limited 27
Testing effectiveness (Phase 2)Study completedNCT00534430
What this trial is testing

Busulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer

Who this might be right for
LeukemiaMyelodysplastic Syndromes
City of Hope Medical Center 30
Testing effectiveness (Phase 2)Ended earlyNCT02587598
What this trial is testing

Study of INCB053914 in Subjects With Advanced Malignancies

Who this might be right for
Solid Tumors
Incyte Corporation 97
Large-scale testing (Phase 3)Study completedNCT00043381
What this trial is testing

Decitabine Versus Supportive Care in Adults With Advanced-stage MDS

Who this might be right for
Myelodysplastic Syndrome
Astex Pharmaceuticals, Inc. 160
Testing effectiveness (Phase 2)Study completedNCT01660607
What this trial is testing

Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell

Who this might be right for
Myeloid Leukemia, ChronicAcute Myelogenous LeukemiaMyelodysplastic Syndromes (MDS)+6 more
Stanford University 68
Early research (Phase 1)WithdrawnNCT00004114
What this trial is testing

Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Active Not RecruitingNCT05455294
What this trial is testing

Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms

Who this might be right for
Myeloid MalignancyMyelodysplastic SyndromesMyelofibrosis+2 more
Jacqueline Garcia, MD 16
Early research (Phase 1)Study completedNCT01314599
What this trial is testing

Clinical Study of PM01183 in Patients With Acute Leukemia or Relapsed/Refractory Myelodysplastic Syndrome

Who this might be right for
Acute Leukemia
PharmaMar 45
Testing effectiveness (Phase 2)Study completedNCT00724009
What this trial is testing

Clofarabine Bone Marrow Cytoreduction

Who this might be right for
Leukemia
University of Chicago 29
Early research (Phase 1)Study completedNCT00002890
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Myelodysplastic Syndrome or Relapsed or Refractory Acute Myeloid Leukemia or Chronic Myelogenous Leukemia

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Memorial Sloan Kettering Cancer Center 24
Large-scale testing (Phase 3)Study completedNCT00003687
What this trial is testing

Treatment for Chronic Pain in Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+6 more
NCIC Clinical Trials Group 87
Early research (Phase 1)Study completedNCT00005634
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Memorial Sloan Kettering Cancer Center
Load More Results